Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

Autor: Kim, Edward S, Neubauer, Marcus, Cohn, Allen, Schwartzberg, Lee, Garbo, Lawrence, Caton, John, Robert, Francisco, Reynolds, Craig, Katz, Terry, Chittoor, Sreeni, Simms, Lorinda, Saxman, Scott
Zdroj: In Lancet Oncology December 2013 14(13):1326-1336
Databáze: ScienceDirect